Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.concorddrugs.in | |
Market Cap | 24.31 Cr. | |
Enterprise Value(EV) | 41.07 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.94 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 28.56 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 32.00 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 32.64 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 0.82 | Calculated using Price: 26.92 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.90 Cr. | 9,029,610 Shares |
FaceValue | 10 | |
Company Profile | ||
Concord Drugs is engaged in developing new products Viz MUPS (Multiple Unit Pellet System), Sustained Release, Modified Release pellets with Innovative Drug Delivery Technologies by utilizing best and latest processing machinery. |
1 Day |
|
+1.85% |
1 Week |
|
-0.59% |
1 Month |
|
-5.54% |
3 Month |
|
-19.40% |
6 Month |
|
-19.40% |
1 Year |
|
-6.04% |
2 Year |
|
-10.27% |
5 Year |
|
+5.57% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 2.72 | 5.37 | 12.32 | 0.94 | 1.69 | 1.92 | 1.41 | 13.06 | 5.78 | |
Return on Capital Employed (%) | 7.15 | 11.33 | 15.90 | 8.84 | 7.49 | 6.17 | 6.06 | 15.69 | 9.30 | |
Return on Assets (%) | 0.79 | 1.41 | 3.28 | 0.30 | 0.40 | 0.43 | 0.47 | 6.08 | 3.00 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 15 | 13 | 15 | 19 | 19 | 23 | 23 | 27 | 28 | 29 | |
Non Curr. Liab. | 12 | 13 | 17 | 7 | 6 | 4 | 7 | 7 | 5 | 5 | |
Curr. Liab. | 18 | 28 | 21 | 29 | 81 | 56 | 27 | 16 | 23 | 20 | |
Minority Int. | |||||||||||
Equity & Liab. | 45 | 54 | 52 | 56 | 106 | 83 | 58 | 50 | 56 | 54 | |
Non Curr. Assets | 21 | 19 | 16 | 25 | 14 | 13 | 12 | 14 | 15 | 14 | |
Curr. Assets | 23 | 36 | 37 | 30 | 92 | 70 | 46 | 36 | 42 | 40 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 45 | 54 | 52 | 56 | 106 | 83 | 58 | 50 | 56 | 54 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 34 | 40 | 51 | 57 | 52 | 48 | 51 | 51 | 59 | 55 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total Income | 34 | 40 | 51 | 58 | 52 | 48 | 51 | 51 | 59 | 55 | |
Total Expenditure | -31 | -33 | -42 | -52 | -47 | -44 | -48 | -48 | -53 | -51 | |
PBIDT | 3 | 7 | 8 | 6 | 5 | 4 | 3 | 3 | 6 | 4 | |
Interest | -2 | -3 | -3 | -2 | -2 | -2 | -2 | -1 | -2 | -1 | |
Depreciation | -1 | -4 | -3 | -3 | -2 | -2 | -1 | -1 | -2 | -2 | |
Taxation | 0 | 0 | -1 | 0 | 0 | 0 | 0 | -1 | -1 | 0 | |
Exceptional Items | 4 | ||||||||||
PAT | 0 | 1 | 2 | 0 | 0 | 0 | 0 | 3 | 2 | 1 | |
Adjusted EPS | 0 | 1 | 2 | 0 | 0 | 1 | 0 | 4 | 2 | 1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 1 | 2 | 2 | 4 | 2 | 7 | 1 | 2 | 2 | 1 | |
Cash Fr. Inv. | -10 | -2 | -1 | 0 | -1 | -2 | 0 | -1 | -4 | 0 | |
Cash Fr. Finan. | 8 | 0 | -1 | -4 | -4 | -5 | -1 | -2 | 2 | 2 | |
Net Change | -1 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 2 | |
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 3 |
Tue, 28 Mar 2023
Closure of Trading Window Closure of trading window under SEBI (Prohibition of Insider Trading) Regulations 2015. |
Tue, 28 Mar 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 28.03.2023. Outcome of Board meeting held on 28.03.2023. |
Mon, 27 Mar 2023
Board Meeting Outcome for Outcome Of Board Meeting Held On 27.03.2023 Outcome of Board meeting held on 27.03.2023 |
Tue, 28 Mar 2023 |
|
|
|
|
|